With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Defining the Cell Surface Landscape of Diagnostic and Relapsed Neuroblastoma: Immunotherapeutic Target Identification||Children's Hospital of Philadelphia / Sharon Diskin, PhD||Innovation Grants||2017||Pennsylvania|
|Natural Killer T cells with an IL-15-armored GD2-specific CAR for Children with Neuroblastoma||Baylor College of Medicine / Andras Heczey, MD||Bio-Therapeutic Impact Award||2017||Texas|
|Targeting Metabolic Vulnerabilities in ETP-ALL||Columbia University / Adolfo A. Ferrando, MD/PhD||Innovation Grants||2017||New York|
|Development of Mithramycin Analogs for Ewing sarcoma||Van Andel Research Institute / Patrick Grohar, MD/PhD||Innovation Grants||2017||Michigan|
|Phase I Study of Lentivirus Engineered Autologous AML Cells Expressing IL-12 in Children and Young Adults with Relapsed AML||Children's Hospital of Wisconsin - Milwaukee / Michael Burke, MD & Jeffrey Medin, MD/PhD||Reach Grants||2017||Wisconsin|
|Targeting Chondroitin Sulphate Proteoglycan 4 (CSPG4) in Glioblastoma||University of North Carolina / Gianpietro Dotti, MD & Barbara Savoldo, MD/PhD||Reach Grants||2017||North Carolina|
|Role of Protocadherin-9 in Enabling Leukemia Cell Colonization of the CNS||National Jewish Health / Jordan Jacobelli, PhD||Innovation Grants||2017||Colorado|
|Therapeutic Targeting of PGBD5-induced DNA Repair Dependency in Pediatric Solid Tumors||Memorial Sloan-Kettering Cancer Center / Alex Kentsis, MD/PhD||Reach Grants||2017||New York|
|Reversing mSWI/SNF (BAF) Complex Misassembly and Genomic Targeting in Human Synovial Sarcoma||Dana-Farber Cancer Institute / Cigall Kadoch, PhD||'A' Award Grants||2017||Massachusetts|
|Novel Approaches to AML Differentiation Therapy||Dana-Farber Cancer Institute / Andrew Lane, MD/PhD||'A' Award Grants||2017||Massachusetts|